VanEck Biotech ETF (BBH) News Today $163.97 +1.62 (+1.00%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Are Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comEmphasize Consistency To Navigate VolatilitySeptember 7, 2024 | seekingalpha.comVanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummaryAugust 29, 2024 | benzinga.com3 Biotech ETFs for a Diversified PortfolioAugust 15, 2024 | stocknews.comTop Biotech Stocks: Exploring Innovation Opportunities (BBH)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesJune 6, 2024 | marketbeat.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 29, 2024 | benzinga.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentMarch 22, 2024 | seekingalpha.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioJanuary 30, 2024 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 19, 2023 | msn.comBBH: A Solid Way To Play A Comeback In BiotechDecember 9, 2023 | seekingalpha.comBBH ETF Stock Price HistoryOctober 24, 2023 | investing.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 82.4%VanEck Biotech ETF (NASDAQ:BBH - Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 6,200 shares, an increase of 82.4% from the August 15th total of 3,400 shares. Based on an average trading volume of 6,400 shares, the days-to-cover ratio is currently 1.0 days.September 14, 2023 | marketbeat.comBBH: Our Favorite Biotech ETF Can Keep OutperformingSeptember 13, 2023 | msn.comQuintet Private Bank Europe S.A. Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Quintet Private Bank Europe S.A. bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,004 shares of the compaSeptember 4, 2023 | marketbeat.comLPL Financial LLC Has $7.81 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)LPL Financial LLC lessened its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 2.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,159 shares of the company's stock after selling 1,284 shares duAugust 30, 2023 | marketbeat.comTower Research Capital LLC TRC Boosts Stock Position in VanEck Biotech ETF (NASDAQ:BBH)Tower Research Capital LLC TRC grew its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 38.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,051 shares of the company's stock after purchaAugust 20, 2023 | marketbeat.comVanEck ETFsAugust 7, 2023 | morningstar.comMiller Investment Management LP Grows Position in VanEck Biotech ETF (NASDAQ:BBH)Miller Investment Management LP raised its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 117.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,623 shares of the company's stock after acquiriJune 2, 2023 | marketbeat.comCommerce Bank Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Commerce Bank acquired a new position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's stock, valued at approximately $May 28, 2023 | marketbeat.comBBH: A Solid Choice For Biotech ExposureMay 27, 2023 | msn.comChevy Chase Trust Holdings LLC Purchases New Holdings in VanEck Biotech ETF (NASDAQ:BBH)Chevy Chase Trust Holdings LLC purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,741 shares of the company's stocMay 23, 2023 | marketbeat.comVan Eck Biotech Etf $BBH Trading ReportMay 13, 2023 | marketwatch.comWhen the Price of Van Eck Biotech Etf $BBH Talks, People ListenMay 3, 2023 | marketwatch.comJanney Montgomery Scott LLC Sells 1,050 Shares of VanEck Biotech ETF (NASDAQ:BBH)Janney Montgomery Scott LLC trimmed its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 13.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,520 shares of the company's stock after selling 1,050 shares during theApril 30, 2023 | marketbeat.comBBH VanEck Biotech ETFApril 25, 2023 | seekingalpha.comVan Eck Biotech Etf $BBH Pivots Trading Plans and Risk ControlsApril 24, 2023 | marketwatch.comKestra Advisory Services LLC Lowers Holdings in VanEck Biotech ETF (NASDAQ:BBH)Kestra Advisory Services LLC reduced its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 8.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,353 shares of the company's stock after selling 1,668 shares during theApril 20, 2023 | marketbeat.comCyndeo Wealth Partners LLC Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Cyndeo Wealth Partners LLC acquired a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's stoApril 7, 2023 | marketbeat.comAspiriant LLC Has $1.21 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)Aspiriant LLC boosted its stake in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 63.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,583 shares of the company's stock after buying an additional 2,955 shares during the period. AspirianMarch 31, 2023 | marketbeat.comTrading Van Eck Biotech Etf $BBH With Integrated Risk ControlsMarch 27, 2023 | marketwatch.comETFs in Focus on Sanofi and Regeneron's COPD Drug DataMarch 24, 2023 | msn.comVanEck Biotech ETF BBHMarch 18, 2023 | morningstar.comAmerican Trust Takes $368,000 Position in VanEck Biotech ETF (NASDAQ:BBH)American Trust purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,328 shares of the company's stock, valued at approximately $368,000. American TruMarch 17, 2023 | marketbeat.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 74.1% in FebruaryVanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 2,200 shares, a decrease of 74.1% from the February 13th total of 8,500 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is currently 0.2 days.March 10, 2023 | marketbeat.comMML Investors Services LLC Buys New Stake in VanEck Biotech ETF (NASDAQ:BBH)MML Investors Services LLC bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,833 shares of the company's stock, valued at approximately $399,000. MMarch 9, 2023 | marketbeat.comWealthspire Advisors LLC Decreases Stake in VanEck Biotech ETF (NASDAQ:BBH)Wealthspire Advisors LLC lowered its position in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 68.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,542 shares of the company's stock after selling 3,365 shares during the period. WealMarch 2, 2023 | marketbeat.comTower Research Capital LLC TRC Sells 2,422 Shares of VanEck Biotech ETF (NASDAQ:BBH)Tower Research Capital LLC TRC trimmed its position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 47.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,683 shares of the company's stock after sellingFebruary 28, 2023 | marketbeat.comFirst Republic Investment Management Inc. Acquires 10,515 Shares of VanEck Biotech ETF (NASDAQ:BBH)First Republic Investment Management Inc. lifted its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 514.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,558 shares of the company'February 1, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Grows Stake in VanEck Biotech ETF (NASDAQ:BBH)Raymond James Financial Services Advisors Inc. lifted its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 11.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,654 shares of theJanuary 19, 2023 | marketbeat.comJanney Montgomery Scott LLC Lowers Stock Holdings in VanEck Biotech ETF (NASDAQ:BBH)Janney Montgomery Scott LLC lowered its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 7.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,570 shares of the company's stock aftJanuary 18, 2023 | marketbeat.comVanEck Vectors Biotech ETF declares annual distribution of $0.7488December 23, 2022 | msn.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 106.6%VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 12,600 shares, an increase of 106.6% from the November 15th total of 6,100 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 1.0 days.December 13, 2022 | marketbeat.comBiotech Finally Getting Its Groove BackNovember 26, 2022 | nasdaq.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 182.1%VanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 31,600 shares, an increase of 182.1% from the October 15th total of 11,200 shares. Based on an average trading volume of 12,900 shares, the short-interest ratio is currently 2.4 days.November 11, 2022 | marketbeat.comIBB iShares Biotechnology ETFOctober 21, 2022 | seekingalpha.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 33.6% in SeptemberOctober 15, 2022 | marketbeat.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 41.3% in SeptemberVanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 11,300 shares, an increase of 41.3% from the August 31st total of 8,000 shares. Based on an average daily volume of 15,100 shares, the short-interest ratio is presently 0.7 days.September 30, 2022 | marketbeat.comConsolidation Case for Biotech ETF BBHSeptember 7, 2022 | nasdaq.comVanEck Biotech ETF (BBH)August 25, 2022 | uk.finance.yahoo.comBiotech Bounce-Back Could Be DurableAugust 17, 2022 | nasdaq.com Get VanEck Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. BBH Media Mentions By Week BBH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBH News Sentiment▼0.000.81▲Average Finance News Sentiment BBH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBH Articles This Week▼00▲BBH Articles Average Week Get VanEck Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PPH News Today PSCH News Today BIB News Today IBBQ News Today BIS News Today IBB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBH) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
